Structured Review

Revvity Signals alkbh1 specific
( a ) <t>ALKBH1</t> and DENV2 NS5 immunoblots of DENV2 NGC-and mock-infected cells (left). Densitometric quantitation of NS5 protein (right). ( b ) siRNA knockdown of ALKBH1 assessed by immunoblotting. ( c ) LC-MS/MS profiling of tRNA modifications in ALKBH1 knockdown versus control knockdown cells. ( d ) DENV2 NS3 immunoblot analysis in ALKBH1 knockdown versus control knockdown cells (left). Densitometry quantitation of NS3 protein (right). ( e ) New virus particle production in ALKBH1 knockdown versus control knockdown cells determined by plaque assay. ( f ) DENV2 NS3 immunoblot analysis in ALKBH1-overexpressing versus control cells (left). Densitometry quantitation of NS3 protein (right). ( g ) LC-MS/MS profiling of tRNA modifications in ALKBH1-overexpressing versus control cells. ( h ) New virus particle production at 24 hpi in ALKBH1-overexpressing versus control cells determined by plaque assay. Graphs in all panels show mean ±} SD for 3 biological replicates. All statistical significance was determined using Student’s t test, *p<0.05; **p<0.01.
Alkbh1 Specific, supplied by Revvity Signals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/alkbh1 specific/product/Revvity Signals
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
alkbh1 specific - by Bioz Stars, 2024-09
86/100 stars

Images

1) Product Images from "Dengue virus exploits the host tRNA epitranscriptome to promote viral replication"

Article Title: Dengue virus exploits the host tRNA epitranscriptome to promote viral replication

Journal: bioRxiv

doi: 10.1101/2023.11.05.565734

( a ) ALKBH1 and DENV2 NS5 immunoblots of DENV2 NGC-and mock-infected cells (left). Densitometric quantitation of NS5 protein (right). ( b ) siRNA knockdown of ALKBH1 assessed by immunoblotting. ( c ) LC-MS/MS profiling of tRNA modifications in ALKBH1 knockdown versus control knockdown cells. ( d ) DENV2 NS3 immunoblot analysis in ALKBH1 knockdown versus control knockdown cells (left). Densitometry quantitation of NS3 protein (right). ( e ) New virus particle production in ALKBH1 knockdown versus control knockdown cells determined by plaque assay. ( f ) DENV2 NS3 immunoblot analysis in ALKBH1-overexpressing versus control cells (left). Densitometry quantitation of NS3 protein (right). ( g ) LC-MS/MS profiling of tRNA modifications in ALKBH1-overexpressing versus control cells. ( h ) New virus particle production at 24 hpi in ALKBH1-overexpressing versus control cells determined by plaque assay. Graphs in all panels show mean ±} SD for 3 biological replicates. All statistical significance was determined using Student’s t test, *p<0.05; **p<0.01.
Figure Legend Snippet: ( a ) ALKBH1 and DENV2 NS5 immunoblots of DENV2 NGC-and mock-infected cells (left). Densitometric quantitation of NS5 protein (right). ( b ) siRNA knockdown of ALKBH1 assessed by immunoblotting. ( c ) LC-MS/MS profiling of tRNA modifications in ALKBH1 knockdown versus control knockdown cells. ( d ) DENV2 NS3 immunoblot analysis in ALKBH1 knockdown versus control knockdown cells (left). Densitometry quantitation of NS3 protein (right). ( e ) New virus particle production in ALKBH1 knockdown versus control knockdown cells determined by plaque assay. ( f ) DENV2 NS3 immunoblot analysis in ALKBH1-overexpressing versus control cells (left). Densitometry quantitation of NS3 protein (right). ( g ) LC-MS/MS profiling of tRNA modifications in ALKBH1-overexpressing versus control cells. ( h ) New virus particle production at 24 hpi in ALKBH1-overexpressing versus control cells determined by plaque assay. Graphs in all panels show mean ±} SD for 3 biological replicates. All statistical significance was determined using Student’s t test, *p<0.05; **p<0.01.

Techniques Used: Western Blot, Infection, Quantitation Assay, Liquid Chromatography with Mass Spectroscopy, Virus, Plaque Assay

Cell viability determined by MTT assay of Huh-7 cells treated with (a) non-targeting and ALKBH1-specific siRNA, and (b) control empty vector and ALKBH1 plasmid, at 24h and 48h post-transfection.
Figure Legend Snippet: Cell viability determined by MTT assay of Huh-7 cells treated with (a) non-targeting and ALKBH1-specific siRNA, and (b) control empty vector and ALKBH1 plasmid, at 24h and 48h post-transfection.

Techniques Used: MTT Assay, Plasmid Preparation, Transfection

( a ) Illustration of ALKBH1 transcript with indicated siRNA-targeting sites. ( b ) Manipulation of ALKBH1 levels by siRNA knockdown, plasmid overexpression, and complementation using a siRNA-resistant ALKBH1 plasmid as assessed by immunoblotting. ( c ) LC-MS/MS profiling of modifications in f 5 Cm biogenesis of cells with indicated treatments versus cells treated with control siRNA and control plasmid. ( d ) Table of ALKBH1-dependent proteins obtained from proteomics analysis of treated cells from panel c . ( e ) Plot of p values derived from analysis of codon Z-scores of ALKBH1 negatively-regulated versus positively-regulated transcripts. ( f,g ) Z-score analysis (number of standard deviations above/below the mean) of leucine ( f ) and arginine ( g ) codons in ALKBH1 negatively-regulated (□) versus ALKBH1 positively-regulated (▪) transcripts. ( h ) Table of GO term and KEGG analysis of proteins deregulated by ALKBH1 depletion assessed by DAVID. Statistical significance was determined using Student’s t test, *p<0.05; **p<0.01.
Figure Legend Snippet: ( a ) Illustration of ALKBH1 transcript with indicated siRNA-targeting sites. ( b ) Manipulation of ALKBH1 levels by siRNA knockdown, plasmid overexpression, and complementation using a siRNA-resistant ALKBH1 plasmid as assessed by immunoblotting. ( c ) LC-MS/MS profiling of modifications in f 5 Cm biogenesis of cells with indicated treatments versus cells treated with control siRNA and control plasmid. ( d ) Table of ALKBH1-dependent proteins obtained from proteomics analysis of treated cells from panel c . ( e ) Plot of p values derived from analysis of codon Z-scores of ALKBH1 negatively-regulated versus positively-regulated transcripts. ( f,g ) Z-score analysis (number of standard deviations above/below the mean) of leucine ( f ) and arginine ( g ) codons in ALKBH1 negatively-regulated (□) versus ALKBH1 positively-regulated (▪) transcripts. ( h ) Table of GO term and KEGG analysis of proteins deregulated by ALKBH1 depletion assessed by DAVID. Statistical significance was determined using Student’s t test, *p<0.05; **p<0.01.

Techniques Used: Plasmid Preparation, Over Expression, Western Blot, Liquid Chromatography with Mass Spectroscopy, Derivative Assay

(a) Densitometric quantitation of NS3 protein levels at indicated times after infection of Huh-7 cells with DENV strain EDEN2 infection. Huh-7 cells were pre-treated with control non-targeting siRNA (blue circles) and ALKBH1-specific siRNA (orange circles). (b) Differences in codon usage frequencies in DENV2 NGC strain versus human host genome. Leucine UUA codon (red arrow) is nearly equally represented in both human and DENV2 genomes, while other leucine codons (black arrows) are not shared equally.
Figure Legend Snippet: (a) Densitometric quantitation of NS3 protein levels at indicated times after infection of Huh-7 cells with DENV strain EDEN2 infection. Huh-7 cells were pre-treated with control non-targeting siRNA (blue circles) and ALKBH1-specific siRNA (orange circles). (b) Differences in codon usage frequencies in DENV2 NGC strain versus human host genome. Leucine UUA codon (red arrow) is nearly equally represented in both human and DENV2 genomes, while other leucine codons (black arrows) are not shared equally.

Techniques Used: Quantitation Assay, Infection

In early stages of DENV infection, host cellular ALKBH1 levels decrease resulting in reduced f 5 Cm-modified ct-tRNA Leu(CAA) reduced decoding of non-cognate UUA codon. Transcripts lacking UUA are consequently preferentially translated and many of which have virus-associated functions, resulting in pro-viral translational remodeling of the host proteome to facilitate viral replication. As the virus replicates and translates its own mRNA, accumulating the MTase NS5 in the cell at later stages of infection, NS5 contributes to f 5 Cm-modification of tRNA, increasing UUA decoding and further cellular translational remodeling that may contribute to viral exocytosis.
Figure Legend Snippet: In early stages of DENV infection, host cellular ALKBH1 levels decrease resulting in reduced f 5 Cm-modified ct-tRNA Leu(CAA) reduced decoding of non-cognate UUA codon. Transcripts lacking UUA are consequently preferentially translated and many of which have virus-associated functions, resulting in pro-viral translational remodeling of the host proteome to facilitate viral replication. As the virus replicates and translates its own mRNA, accumulating the MTase NS5 in the cell at later stages of infection, NS5 contributes to f 5 Cm-modification of tRNA, increasing UUA decoding and further cellular translational remodeling that may contribute to viral exocytosis.

Techniques Used: Infection, Modification, Virus

Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86
    Revvity Signals alkbh1 specific
    ( a ) <t>ALKBH1</t> and DENV2 NS5 immunoblots of DENV2 NGC-and mock-infected cells (left). Densitometric quantitation of NS5 protein (right). ( b ) siRNA knockdown of ALKBH1 assessed by immunoblotting. ( c ) LC-MS/MS profiling of tRNA modifications in ALKBH1 knockdown versus control knockdown cells. ( d ) DENV2 NS3 immunoblot analysis in ALKBH1 knockdown versus control knockdown cells (left). Densitometry quantitation of NS3 protein (right). ( e ) New virus particle production in ALKBH1 knockdown versus control knockdown cells determined by plaque assay. ( f ) DENV2 NS3 immunoblot analysis in ALKBH1-overexpressing versus control cells (left). Densitometry quantitation of NS3 protein (right). ( g ) LC-MS/MS profiling of tRNA modifications in ALKBH1-overexpressing versus control cells. ( h ) New virus particle production at 24 hpi in ALKBH1-overexpressing versus control cells determined by plaque assay. Graphs in all panels show mean ±} SD for 3 biological replicates. All statistical significance was determined using Student’s t test, *p<0.05; **p<0.01.
    Alkbh1 Specific, supplied by Revvity Signals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alkbh1 specific/product/Revvity Signals
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    alkbh1 specific - by Bioz Stars, 2024-09
    86/100 stars
      Buy from Supplier

    Image Search Results


    ( a ) ALKBH1 and DENV2 NS5 immunoblots of DENV2 NGC-and mock-infected cells (left). Densitometric quantitation of NS5 protein (right). ( b ) siRNA knockdown of ALKBH1 assessed by immunoblotting. ( c ) LC-MS/MS profiling of tRNA modifications in ALKBH1 knockdown versus control knockdown cells. ( d ) DENV2 NS3 immunoblot analysis in ALKBH1 knockdown versus control knockdown cells (left). Densitometry quantitation of NS3 protein (right). ( e ) New virus particle production in ALKBH1 knockdown versus control knockdown cells determined by plaque assay. ( f ) DENV2 NS3 immunoblot analysis in ALKBH1-overexpressing versus control cells (left). Densitometry quantitation of NS3 protein (right). ( g ) LC-MS/MS profiling of tRNA modifications in ALKBH1-overexpressing versus control cells. ( h ) New virus particle production at 24 hpi in ALKBH1-overexpressing versus control cells determined by plaque assay. Graphs in all panels show mean ±} SD for 3 biological replicates. All statistical significance was determined using Student’s t test, *p<0.05; **p<0.01.

    Journal: bioRxiv

    Article Title: Dengue virus exploits the host tRNA epitranscriptome to promote viral replication

    doi: 10.1101/2023.11.05.565734

    Figure Lengend Snippet: ( a ) ALKBH1 and DENV2 NS5 immunoblots of DENV2 NGC-and mock-infected cells (left). Densitometric quantitation of NS5 protein (right). ( b ) siRNA knockdown of ALKBH1 assessed by immunoblotting. ( c ) LC-MS/MS profiling of tRNA modifications in ALKBH1 knockdown versus control knockdown cells. ( d ) DENV2 NS3 immunoblot analysis in ALKBH1 knockdown versus control knockdown cells (left). Densitometry quantitation of NS3 protein (right). ( e ) New virus particle production in ALKBH1 knockdown versus control knockdown cells determined by plaque assay. ( f ) DENV2 NS3 immunoblot analysis in ALKBH1-overexpressing versus control cells (left). Densitometry quantitation of NS3 protein (right). ( g ) LC-MS/MS profiling of tRNA modifications in ALKBH1-overexpressing versus control cells. ( h ) New virus particle production at 24 hpi in ALKBH1-overexpressing versus control cells determined by plaque assay. Graphs in all panels show mean ±} SD for 3 biological replicates. All statistical significance was determined using Student’s t test, *p<0.05; **p<0.01.

    Article Snippet: Transfections were performed using 25 nM ALKBH1-specific (8846, Dharmacon) or non-targeting control (D-001810-10-05, Dharmacon) siRNA, 500 ng plasmid DNA and lipofectamine 3000 (Invitrogen) as indicated, according to the manufacturer’s instructions.

    Techniques: Western Blot, Infection, Quantitation Assay, Liquid Chromatography with Mass Spectroscopy, Virus, Plaque Assay

    Cell viability determined by MTT assay of Huh-7 cells treated with (a) non-targeting and ALKBH1-specific siRNA, and (b) control empty vector and ALKBH1 plasmid, at 24h and 48h post-transfection.

    Journal: bioRxiv

    Article Title: Dengue virus exploits the host tRNA epitranscriptome to promote viral replication

    doi: 10.1101/2023.11.05.565734

    Figure Lengend Snippet: Cell viability determined by MTT assay of Huh-7 cells treated with (a) non-targeting and ALKBH1-specific siRNA, and (b) control empty vector and ALKBH1 plasmid, at 24h and 48h post-transfection.

    Article Snippet: Transfections were performed using 25 nM ALKBH1-specific (8846, Dharmacon) or non-targeting control (D-001810-10-05, Dharmacon) siRNA, 500 ng plasmid DNA and lipofectamine 3000 (Invitrogen) as indicated, according to the manufacturer’s instructions.

    Techniques: MTT Assay, Plasmid Preparation, Transfection

    ( a ) Illustration of ALKBH1 transcript with indicated siRNA-targeting sites. ( b ) Manipulation of ALKBH1 levels by siRNA knockdown, plasmid overexpression, and complementation using a siRNA-resistant ALKBH1 plasmid as assessed by immunoblotting. ( c ) LC-MS/MS profiling of modifications in f 5 Cm biogenesis of cells with indicated treatments versus cells treated with control siRNA and control plasmid. ( d ) Table of ALKBH1-dependent proteins obtained from proteomics analysis of treated cells from panel c . ( e ) Plot of p values derived from analysis of codon Z-scores of ALKBH1 negatively-regulated versus positively-regulated transcripts. ( f,g ) Z-score analysis (number of standard deviations above/below the mean) of leucine ( f ) and arginine ( g ) codons in ALKBH1 negatively-regulated (□) versus ALKBH1 positively-regulated (▪) transcripts. ( h ) Table of GO term and KEGG analysis of proteins deregulated by ALKBH1 depletion assessed by DAVID. Statistical significance was determined using Student’s t test, *p<0.05; **p<0.01.

    Journal: bioRxiv

    Article Title: Dengue virus exploits the host tRNA epitranscriptome to promote viral replication

    doi: 10.1101/2023.11.05.565734

    Figure Lengend Snippet: ( a ) Illustration of ALKBH1 transcript with indicated siRNA-targeting sites. ( b ) Manipulation of ALKBH1 levels by siRNA knockdown, plasmid overexpression, and complementation using a siRNA-resistant ALKBH1 plasmid as assessed by immunoblotting. ( c ) LC-MS/MS profiling of modifications in f 5 Cm biogenesis of cells with indicated treatments versus cells treated with control siRNA and control plasmid. ( d ) Table of ALKBH1-dependent proteins obtained from proteomics analysis of treated cells from panel c . ( e ) Plot of p values derived from analysis of codon Z-scores of ALKBH1 negatively-regulated versus positively-regulated transcripts. ( f,g ) Z-score analysis (number of standard deviations above/below the mean) of leucine ( f ) and arginine ( g ) codons in ALKBH1 negatively-regulated (□) versus ALKBH1 positively-regulated (▪) transcripts. ( h ) Table of GO term and KEGG analysis of proteins deregulated by ALKBH1 depletion assessed by DAVID. Statistical significance was determined using Student’s t test, *p<0.05; **p<0.01.

    Article Snippet: Transfections were performed using 25 nM ALKBH1-specific (8846, Dharmacon) or non-targeting control (D-001810-10-05, Dharmacon) siRNA, 500 ng plasmid DNA and lipofectamine 3000 (Invitrogen) as indicated, according to the manufacturer’s instructions.

    Techniques: Plasmid Preparation, Over Expression, Western Blot, Liquid Chromatography with Mass Spectroscopy, Derivative Assay

    (a) Densitometric quantitation of NS3 protein levels at indicated times after infection of Huh-7 cells with DENV strain EDEN2 infection. Huh-7 cells were pre-treated with control non-targeting siRNA (blue circles) and ALKBH1-specific siRNA (orange circles). (b) Differences in codon usage frequencies in DENV2 NGC strain versus human host genome. Leucine UUA codon (red arrow) is nearly equally represented in both human and DENV2 genomes, while other leucine codons (black arrows) are not shared equally.

    Journal: bioRxiv

    Article Title: Dengue virus exploits the host tRNA epitranscriptome to promote viral replication

    doi: 10.1101/2023.11.05.565734

    Figure Lengend Snippet: (a) Densitometric quantitation of NS3 protein levels at indicated times after infection of Huh-7 cells with DENV strain EDEN2 infection. Huh-7 cells were pre-treated with control non-targeting siRNA (blue circles) and ALKBH1-specific siRNA (orange circles). (b) Differences in codon usage frequencies in DENV2 NGC strain versus human host genome. Leucine UUA codon (red arrow) is nearly equally represented in both human and DENV2 genomes, while other leucine codons (black arrows) are not shared equally.

    Article Snippet: Transfections were performed using 25 nM ALKBH1-specific (8846, Dharmacon) or non-targeting control (D-001810-10-05, Dharmacon) siRNA, 500 ng plasmid DNA and lipofectamine 3000 (Invitrogen) as indicated, according to the manufacturer’s instructions.

    Techniques: Quantitation Assay, Infection

    In early stages of DENV infection, host cellular ALKBH1 levels decrease resulting in reduced f 5 Cm-modified ct-tRNA Leu(CAA) reduced decoding of non-cognate UUA codon. Transcripts lacking UUA are consequently preferentially translated and many of which have virus-associated functions, resulting in pro-viral translational remodeling of the host proteome to facilitate viral replication. As the virus replicates and translates its own mRNA, accumulating the MTase NS5 in the cell at later stages of infection, NS5 contributes to f 5 Cm-modification of tRNA, increasing UUA decoding and further cellular translational remodeling that may contribute to viral exocytosis.

    Journal: bioRxiv

    Article Title: Dengue virus exploits the host tRNA epitranscriptome to promote viral replication

    doi: 10.1101/2023.11.05.565734

    Figure Lengend Snippet: In early stages of DENV infection, host cellular ALKBH1 levels decrease resulting in reduced f 5 Cm-modified ct-tRNA Leu(CAA) reduced decoding of non-cognate UUA codon. Transcripts lacking UUA are consequently preferentially translated and many of which have virus-associated functions, resulting in pro-viral translational remodeling of the host proteome to facilitate viral replication. As the virus replicates and translates its own mRNA, accumulating the MTase NS5 in the cell at later stages of infection, NS5 contributes to f 5 Cm-modification of tRNA, increasing UUA decoding and further cellular translational remodeling that may contribute to viral exocytosis.

    Article Snippet: Transfections were performed using 25 nM ALKBH1-specific (8846, Dharmacon) or non-targeting control (D-001810-10-05, Dharmacon) siRNA, 500 ng plasmid DNA and lipofectamine 3000 (Invitrogen) as indicated, according to the manufacturer’s instructions.

    Techniques: Infection, Modification, Virus